Aug 11
Earnings call
Q2 2022 earnings call
CODX · Co-Diagnostics, Inc. · Documents
$0.26
-0.01 (-4.12%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that substantial doubt exists about the Company’s ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued. These uncertainties create substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$2.72M
Shares
10.51M
Volume · Nov 13
591.94K
Avg daily vol (3M)
1.97M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Aug 11
Current report
8-K
Financial results, Regulation FD disclosure
Aug 11
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $5.02M
▼ 81.6%
Net loss $2.69M
Diluted EPS -$0.08
Jul 20
Proxy statement
DEF 14A
Proxy statement
Jun 16
Current report
8-K
Events of Jun 10
Entered into a material agreement
May 12
Earnings call
Q1 2022 earnings call
May 12
Current report
8-K
Financial results, Regulation FD disclosure
May 12
Quarterly report
10-Q
FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $22.7M
▲ 13.4%
Net income $11.71M
▲ 48.3%
Diluted EPS $0.34
▲ 30.8%
Apr 1
Current report
8-K
Events of Mar 31
Charter or bylaw amendment, or fiscal year change
Mar 24
Earnings call
Q4 2021 earnings call
Mar 24
Current report
8-K
Financial results, Regulation FD disclosure
Mar 24
Annual report
10-K
FY2021, ended Dec 31
Annual report for FY2021
Revenue $97.89M
▲ 31.3%
Net income $36.66M
▼ 13.7%
Diluted EPS $1.23
▼ 19.1%
Mar 15
Current report
8-K
Regulation FD disclosure, Other events
2021
Dec 23
Current report
8-K
Events of Dec 21
Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure
Nov 12
Earnings call
Q3 2021 earnings call
Nov 12
Current report
8-K
Events of Nov 11
Financial results, Regulation FD disclosure
Nov 12
Quarterly report
10-Q
FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $30.1M
▲ 38.0%
Net income $11.48M
▼ 27.1%
Diluted EPS $0.38
▼ 28.3%
Aug 12
Earnings call
Q2 2021 earnings call
Aug 12
Current report
8-K
Financial results, Regulation FD disclosure
Aug 12
Quarterly report
10-Q
FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $27.36M
▲ 13.8%
Net income $9.79M
▼ 34.8%
Diluted EPS $0.33
▼ 35.3%
Aug 5
Current report
8-K
Events of Aug 4
Shareholder vote results
Jul 9
Current report
8-K
Events of Jul 8
Director or officer change, or executive pay
Jun 22
Proxy statement
DEF 14A
Proxy statement
May 13
Earnings call
Q1 2021 earnings call
May 13
Current report
8-K
Financial results, Regulation FD disclosure
May 13
Quarterly report
10-Q
FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $20.02M
▲ 1193.1%
Net income $7.9M
Diluted EPS $0.26
Mar 26
Current report
8-K
Events of Mar 25
Financial results, Regulation FD disclosure
Mar 25
Annual report
10-K
FY2020, ended Dec 31
Annual report for FY2020
Revenue $74.55M
▲ 34579.9%
Net income $42.48M
Diluted EPS $1.52
Feb 22
Current report
8-K
Director or officer change, or executive pay
Jan 6
Earnings call
Q4 2020 earnings call
Jan 6
Current report
8-K
Financial results, Regulation FD disclosure
2020
Dec 17
Current report
8-K
Events of Dec 16
Shareholder vote results
Nov 16
Earnings call
Q3 2020 earnings call
Nov 16
Current report
8-K
Financial results, Regulation FD disclosure
Nov 16
Quarterly report
10-Q
FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $21.82M
▲ 52559.1%
Net income $15.73M
Diluted EPS $0.53
Nov 3
Proxy statement
DEF 14A
Proxy statement
Nov 3
Quarterly report
10-Q/A
FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $24.04M
▲ 38942.9%
Net income $15.01M
Diluted EPS $0.51
Nov 3
Proxy statement
DEFA14A
Proxy statement
Nov 2
Current report
8-K
Events of Oct 30
Earlier financial statements no longer reliable, Regulation FD disclosure
Oct 23
Registration statement
S-3
Registration statement
Aug 13
Quarterly report
10-Q
FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $24.04M
▲ 38942.9%
Net income $12.64M
Diluted EPS $0.43
Jun 30
Earnings call
Q2 2020 earnings call
May 15
Current report
8-K
Events of May 14
Financial results, Regulation FD disclosure
May 14
Quarterly report
10-Q
FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $1.55M
▲ 45444.9%
Net loss $1.07M
Mar 30
Annual report
10-K
FY2019, ended Dec 31
Annual report for FY2019
Revenue $214.97K
▲ 438.6%
Net loss $6.2M
Feb 27
Current report
8-K
Entered into a material agreement, Other events
Feb 19
Current report
8-K
Events of Feb 13
Other events
Feb 11
Current report
8-K
Events of Feb 10
Entered into a material agreement, Other events
Jan 27
Current report
8-K
Events of Jan 23
Entered into a material agreement, Other events
Showing 101–149 of 149 documents
Key facts
CIK
1692415
CUSIP
189763204
13F (30d)
30 filings
20 filers
Visit website
Investor relations